Thus, the phospholamban R14del cardiomyopathy portends a much worse prognosis compared to those with ‘typical’ ARVC or DCM, potentially influencing decision-making surrounding advanced heart failure management. The gene discussed is PLN; the disease is arrhythmogenic right ventricular cardiomyopathy.